Aldo Recinos Soto
Pediatric Gastroenterology · Baton Rouge, LANPI 1568848281
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,187, more than ten times the $110 reported in 2020. Among pediatric gastroenterology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $25.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$461
- Regeneron Healthcare Solutions, Inc.$459
- QOL Medical, LLC$414
- Ipsen Biopharmaceuticals, Inc$208
- AbbVie$202
- AstraZeneca$191
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,915100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 17 | $461 |
| Regeneron Healthcare Solutions, Inc. | 10 | $459 |
| QOL Medical, LLC | 17 | $414 |
| Ipsen Biopharmaceuticals, Inc | 5 | $208 |
| AbbVie | 11 | $202 |
| AstraZeneca(2 entities) | 9 | $191 |
| Mallinckrodt Hospital Products Inc. | 9 | $177 |
| Mirum Pharmaceuticals, Inc. | 4 | $172 |
| Azurity Pharmaceuticals, Inc. | 7 | $157 |
| Alcresta Therapeutics, Inc. | 4 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $141 |
| Ultragenyx Pharmaceutical Inc. | 6 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $110 |
| Tolmar, Inc. | 5 | $104 |
| Neurocrine Biosciences, Inc. | 4 | $92 |
| Dexcom, Inc. | 4 | $87 |
| Ascendis Pharma Endocrinology Inc | 3 | $75 |
| Kyowa Kirin, Inc. | 4 | $70 |
| Nestle Healthcare Nutrition Inc. | 2 | $63 |
| Travere Therapeutics, Inc. | 4 | $56 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Cumberland Pharmaceuticals, Inc. | 3 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Apellis Pharmaceuticals, Inc. | 2 | $36 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Albireo Pharma, Inc. | 2 | $27 |
| Ironwood Pharmaceuticals, Inc | 1 | $26 |
| Novartis | 1 | $26 |
| Amryt Pharma Holdings Ltd | 1 | $25 |
| Amgen | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| BD | 1 | $14 |
| Eton Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,916 in reported general payments places this provider in the 90th percentile of 30 pediatric gastroenterology providers in Louisiana.
Other pediatric gastroenterology in Baton Rouge
- Elizabeth AlonsoBaton Rouge$2K
- Elizabeth McDonoughBaton Rouge$2K
- Patrice TysonBaton Rouge$2K
- Rachel BernardBaton Rouge$1K
- Bradley AndingBaton Rouge$392
- Prathipa SanthanamBaton Rouge$153
- Ian KangBaton Rouge$0
- Ryan HimesNew Orleans$114K
- Patricio AriasNew Orleans$90K
- Brian MorrisNew Orleans$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.